메뉴 건너뛰기




Volumn 11, Issue 1, 2007, Pages 34-46

Bleeding following deep hypothermia and circulatory arrest in children

Author keywords

Antifibrinolytics; Circulatory arrest; Coagulopathy; Hypothermia; Platelet dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; APROTININ; DESMOPRESSIN; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

EID: 33847107665     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253206297413     Document Type: Review
Times cited : (32)

References (101)
  • 1
    • 13144285689 scopus 로고    scopus 로고
    • Blood collection and transfusion in the United States in 1999
    • Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion. 2005 ; 45: 141-148.
    • (2005) Transfusion , vol.45 , pp. 141-148
    • Sullivan, M.T.1    Wallace, E.L.2
  • 2
    • 0037343942 scopus 로고    scopus 로고
    • Use of sentinel sites for daily monitoring of the US blood supply
    • Nightingale S, Wanamaker V, Silverman B, et al. Use of sentinel sites for daily monitoring of the US blood supply. Transfusion. 2003 ; 43: 364-372.
    • (2003) Transfusion , vol.43 , pp. 364-372
    • Nightingale, S.1    Wanamaker, V.2    Silverman, B.3
  • 3
    • 2442481588 scopus 로고    scopus 로고
    • Transfusion Medicine: Support of patients undergoing cardiac surgery
    • Goodnough LT, Despotis GJ. Transfusion Medicine: support of patients undergoing cardiac surgery. Am J Cardiovasc Drugs. 2001 ; 1: 337-351.
    • (2001) Am J Cardiovasc Drugs , vol.1 , pp. 337-351
    • Goodnough, L.T.1    Despotis, G.J.2
  • 4
    • 0025972274 scopus 로고
    • Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children
    • Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood and components after open heart surgery in children. Blood. 1991 ; 77: 930-936.
    • (1991) Blood , vol.77 , pp. 930-936
    • Manno, C.S.1    Hedberg, K.W.2    Kim, H.C.3
  • 5
    • 5344278329 scopus 로고    scopus 로고
    • Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants
    • Mou SS, Giroir BP, Molitor-Kirsch EA, et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med. 2004 ; 351: 1635-1644.
    • (2004) N Engl J Med , vol.351 , pp. 1635-1644
    • Mou, S.S.1    Giroir, B.P.2    Molitor-Kirsch, E.A.3
  • 6
    • 0033014430 scopus 로고    scopus 로고
    • Factors associated with blood loss and blood product transfusions: A multivariate analysis on children after open-heart surgery
    • Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis on children after open-heart surgery. Anesth Analg. 1999 ; 89: 57-64.
    • (1999) Anesth Analg , vol.89 , pp. 57-64
    • Williams, G.D.1    Bratton, S.L.2    Ramamoorthy, C.3
  • 7
    • 0032865938 scopus 로고    scopus 로고
    • Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery
    • Williams GD, Bratton SL, Riley EC, et al. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1999 ; 13: 398-404.
    • (1999) J Cardiothorac Vasc Anesth , vol.13 , pp. 398-404
    • Williams, G.D.1    Bratton, S.L.2    Riley, E.C.3
  • 8
    • 33747618377 scopus 로고    scopus 로고
    • Physiology and techniques of extracorporeal circulation in the Pediatric Patient
    • Lake CL, Booker PD, eds. 4th ed. Philadelphia: Lippincott Williams & Wilkins;
    • DiNardo J. Physiology and techniques of extracorporeal circulation in the Pediatric Patient. In: Lake CL, Booker PD, eds. Pediatric Cardiac Anesthesia. 4th ed. Philadelphia: Lippincott Williams & Wilkins ; 2005: 228-252.
    • (2005) Pediatric Cardiac Anesthesia , pp. 228-252
    • Dinardo, J.1
  • 9
    • 0027275986 scopus 로고
    • Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss
    • Boldt J, Knothe C, Zickmann B, et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg. 1993 ; 105: 705-711.
    • (1993) J Thorac Cardiovasc Surg , vol.105 , pp. 705-711
    • Boldt, J.1    Knothe, C.2    Zickmann, B.3
  • 10
    • 0027241263 scopus 로고
    • Aprotinin in pediatric cardiac operations: Platelet function, blood loss and use of homologous blood
    • Boldt J, Knothe C, Zickmann B, et al. Aprotinin in pediatric cardiac operations: platelet function, blood loss and use of homologous blood. Ann Thorac Surg. 1993 ; 55: 1460-1466.
    • (1993) Ann Thorac Surg , vol.55 , pp. 1460-1466
    • Boldt, J.1    Knothe, C.2    Zickmann, B.3
  • 11
    • 0023608558 scopus 로고
    • Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass
    • van Oeveren, W, Jansen NJ, Bidstrup BP, et al. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987 ; 44: 640-645.
    • (1987) Ann Thorac Surg , vol.44 , pp. 640-645
    • Van Oeveren, W.1    Jansen, N.J.2    Bidstrup, B.P.3
  • 12
    • 0026792857 scopus 로고
    • Maturation of the hemostatic system during childhood
    • Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood. 1992 ; 80: 1998-2005.
    • (1992) Blood , vol.80 , pp. 1998-2005
    • Andrew, M.1    Vegh, P.2    Johnston, M.3
  • 13
    • 0036945831 scopus 로고    scopus 로고
    • Coagulation abnormalities in patients with cyanotic congenital heart disease
    • Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2002 ; 16: 752-765.
    • (2002) J Cardiothorac Vasc Anesth , vol.16 , pp. 752-765
    • Tempe, D.K.1    Virmani, S.2
  • 14
    • 0014732565 scopus 로고
    • Hemostasis in cyanotic congenital heart disease
    • Ekert H, Gilchrist GS, Stanton R, et al. Hemostasis in cyanotic congenital heart disease. J Pediatr. 1970 ; 76: 221-230.
    • (1970) J Pediatr , vol.76 , pp. 221-230
    • Ekert, H.1    Gilchrist, G.S.2    Stanton, R.3
  • 15
    • 0026785646 scopus 로고
    • Coagulation defects in neonates during cardiopulmonary bypass
    • Kern FH, Morana NJ, Sears JJ, et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg. 1992 ; 54: 541-546.
    • (1992) Ann Thorac Surg , vol.54 , pp. 541-546
    • Kern, F.H.1    Morana, N.J.2    Sears, J.J.3
  • 16
    • 0026708757 scopus 로고
    • Response to heparinization in adults and children undergoing cardiac operations
    • Horkay F, Martin P, Rajah M, et al. Response to heparinization in adults and children undergoing cardiac operations. Ann Thorac Surg. 1992 ; 53: 822-826.
    • (1992) Ann Thorac Surg , vol.53 , pp. 822-826
    • Horkay, F.1    Martin, P.2    Rajah, M.3
  • 17
    • 0028809946 scopus 로고
    • Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
    • Khuri SF, Valeri CR, Loscalzo J, et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 1995 ; 60: 1008-1014.
    • (1995) Ann Thorac Surg , vol.60 , pp. 1008-1014
    • Khuri, S.F.1    Valeri, C.R.2    Loscalzo, J.3
  • 18
    • 0027310437 scopus 로고
    • The platelet function defect of cardiopulmonary bypass
    • Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood. 1993 ; 82: 107-117.
    • (1993) Blood , vol.82 , pp. 107-117
    • Kestin, A.S.1    Valeri, C.R.2    Khuri, S.F.3
  • 19
    • 0345487533 scopus 로고    scopus 로고
    • Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor
    • Xiao Z, Theroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation. 1998 ; 97: 251-256.
    • (1998) Circulation , vol.97 , pp. 251-256
    • Xiao, Z.1    Theroux, P.2
  • 20
    • 0034124723 scopus 로고    scopus 로고
    • The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood cytometry
    • Kozek-Langenecker SA, Mohammad SF, Masaki T, et al. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood cytometry. Anesth Analg. 2000 ; 90: 808-812.
    • (2000) Anesth Analg , vol.90 , pp. 808-812
    • Kozek-Langenecker, S.A.1    Mohammad, S.F.2    Masaki, T.3
  • 21
    • 0033850594 scopus 로고    scopus 로고
    • The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass
    • Muriithi EW, Belcher PR, Rao JN, et al. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000 ; 120: 538-543.
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 538-543
    • Muriithi, E.W.1    Belcher, P.R.2    Rao, J.N.3
  • 22
    • 0033922114 scopus 로고    scopus 로고
    • Heparin-induced platelet dysfunction and cardiopulmonary bypass
    • Muriithi EW, Belcher PR, Day SP, et al. Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg. 2000 ; 69: 1827-1832.
    • (2000) Ann Thorac Surg , vol.69 , pp. 1827-1832
    • Muriithi, E.W.1    Belcher, P.R.2    Day, S.P.3
  • 23
    • 0036796602 scopus 로고    scopus 로고
    • Lipolysis generates platelet dysfunction after in vivo heparin administration
    • Muriithi EW, Belcher PR, Day SP, et al. Lipolysis generates platelet dysfunction after in vivo heparin administration. Clin Sci (Lond). 2002 ; 103: 433-440.
    • (2002) Clin Sci (Lond) , vol.103 , pp. 433-440
    • Muriithi, E.W.1    Belcher, P.R.2    Day, S.P.3
  • 24
    • 7944231168 scopus 로고    scopus 로고
    • Coagulation disorders of cardiopulmonary bypass: A review
    • Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004 ; 30: 1873-1881.
    • (2004) Intensive Care Med , vol.30 , pp. 1873-1881
    • Paparella, D.1    Brister, S.J.2    Buchanan, M.R.3
  • 25
    • 0141453790 scopus 로고    scopus 로고
    • Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest
    • Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003 ; 21: 527-551.
    • (2003) Anesthesiol Clin North America , vol.21 , pp. 527-551
    • Green, J.A.1    Spiess, B.D.2
  • 26
    • 0029052424 scopus 로고
    • The impact of heparin concentration and activated clotting time monitoring on blood conservation. a prospective, randomized evaluation in patients undergoing cardiac operation
    • Despotis GJ, Joist JH, Hogue CW Jr, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995 ; 110: 46-54.
    • (1995) J Thorac Cardiovasc Surg , vol.110 , pp. 46-54
    • Despotis, G.J.1    Joist, J.H.2    Hogue Jr., C.W.3
  • 27
    • 8044257128 scopus 로고    scopus 로고
    • More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT
    • Despotis GJ, Joist JH, Hogue CW Jr, et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost. 1996 ; 76: 902-908.
    • (1996) Thromb Haemost , vol.76 , pp. 902-908
    • Despotis, G.J.1    Joist, J.H.2    Hogue Jr., C.W.3
  • 28
    • 0029075636 scopus 로고
    • Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations
    • Jobes DR, Aitken GJ, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995 ; 110: 36-45.
    • (1995) J Thorac Cardiovasc Surg , vol.110 , pp. 36-45
    • Jobes, D.R.1    Aitken, G.J.2    Shaffer, G.W.3
  • 29
    • 0030028375 scopus 로고    scopus 로고
    • Factors associated with excessive post-operative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
    • Despotis GJ, Filos KS, Zoys TN, et al. Factors associated with excessive post-operative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg. 1996 ; 82: 13-21.
    • (1996) Anesth Analg , vol.82 , pp. 13-21
    • Despotis, G.J.1    Filos, K.S.2    Zoys, T.N.3
  • 30
    • 0030948890 scopus 로고    scopus 로고
    • The effects of heparinase-1 and protamine on platelet reactivity
    • Ammar T, Fisher C. The effects of heparinase-1 and protamine on platelet reactivity. Anesthesiology. 1997 ; 86: 1382-1386.
    • (1997) Anesthesiology , vol.86 , pp. 1382-1386
    • Ammar, T.1    Fisher, C.2
  • 31
    • 0032775491 scopus 로고    scopus 로고
    • Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass
    • Shigeta O, Kojima H, Hiramatsu Y, et al. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999 ; 118: 354-360.
    • (1999) J Thorac Cardiovasc Surg , vol.118 , pp. 354-360
    • Shigeta, O.1    Kojima, H.2    Hiramatsu, Y.3
  • 32
    • 0031687988 scopus 로고    scopus 로고
    • Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass
    • Mochizuki T, Olson PJ, Szlam F, et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998 ; 87: 781-785.
    • (1998) Anesth Analg , vol.87 , pp. 781-785
    • Mochizuki, T.1    Olson, P.J.2    Szlam, F.3
  • 33
    • 0028196878 scopus 로고
    • Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro
    • Michelson AD, MacGregor H, Barnard MR, et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 1994 ; 71: 633-640.
    • (1994) Thromb Haemost , vol.71 , pp. 633-640
    • Michelson, A.D.1    MacGregor, H.2    Barnard, M.R.3
  • 34
    • 0026695183 scopus 로고
    • Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass
    • Valeri CR, Khabbaz K, Khuri SF, et al. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg. 1992 ; 104: 108-116.
    • (1992) J Thorac Cardiovasc Surg , vol.104 , pp. 108-116
    • Valeri, C.R.1    Khabbaz, K.2    Khuri, S.F.3
  • 35
    • 0030200372 scopus 로고    scopus 로고
    • Normothermic versus hypothermic cardiopulmonary bypass: Do changes in coagulation differ?
    • Boldt J, Knothe C, Welters I, et al. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ? Ann Thorac Surg. 1996 ; 62: 130-135.
    • (1996) Ann Thorac Surg , vol.62 , pp. 130-135
    • Boldt, J.1    Knothe, C.2    Welters, I.3
  • 36
    • 0029078918 scopus 로고
    • Platelet activation in warm and cold heart surgery
    • Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg. 1995 ; 59: 1481-1486.
    • (1995) Ann Thorac Surg , vol.59 , pp. 1481-1486
    • Mazer, C.D.1    Hornstein, A.2    Freedman, J.3
  • 37
    • 28144443221 scopus 로고    scopus 로고
    • Sustained hypothermia accelerates microvascular thrombus formation in mice
    • Lindenblatt N, Menger MD, Klar E, et al. Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol (Heart Circ Physiol). 2005 ; 289: H2680 - H2687.
    • (2005) Am J Physiol (Heart Circ Physiol) , vol.289
    • Lindenblatt, N.1    Menger, M.D.2    Klar, E.3
  • 38
    • 0031749074 scopus 로고    scopus 로고
    • In vitro hypothermia enhances platelet GPIIb/IIIa activation and P-selectin expression
    • Faraday N, Rosenfeld BA. In vitro hypothermia enhances platelet GPIIb/IIIa activation and P-selectin expression. Anesthesiology. 1998 ; 88: 1579-1585.
    • (1998) Anesthesiology , vol.88 , pp. 1579-1585
    • Faraday, N.1    Rosenfeld, B.A.2
  • 39
    • 0036134077 scopus 로고    scopus 로고
    • Hypothermiainduced platelet aggregation in heparinized flowing human blood: Identification of a high responder subpopulation
    • Hall MW, Goodman PD, Alston SM, et al. Hypothermiainduced platelet aggregation in heparinized flowing human blood: identification of a high responder subpopulation. Am J Hematology. 2002 ; 69: 45-55.
    • (2002) Am J Hematology , vol.69 , pp. 45-55
    • Hall, M.W.1    Goodman, P.D.2    Alston, S.M.3
  • 40
    • 22144492951 scopus 로고    scopus 로고
    • Hypothermiainduced platelet aggregation and cognitive decline in coronary artery bypass surgery: A pilot study
    • Hall MW, Hopkins RO, Long JW, et al. Hypothermiainduced platelet aggregation and cognitive decline in coronary artery bypass surgery: a pilot study. Perfusion. 2005 ; 20: 157-167.
    • (2005) Perfusion , vol.20 , pp. 157-167
    • Hall, M.W.1    Hopkins, R.O.2    Long, J.W.3
  • 41
    • 21344435080 scopus 로고    scopus 로고
    • Randomized controlled trials of aprotinin in cardiac surgery: Could clinical equipoise have stopped the bleeding?
    • Fergusson D, Glass KC, Hutton B, et al. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? Clin Trials. 2005 ; 2: 218-232.
    • (2005) Clin Trials , vol.2 , pp. 218-232
    • Fergusson, D.1    Glass, K.C.2    Hutton, B.3
  • 42
    • 0031415922 scopus 로고    scopus 로고
    • Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analysis using perioperative blood transfusion as the outcome
    • Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analysis using perioperative blood transfusion as the outcome. Anesth Analg. 1997 ; 85: 1258-1267.
    • (1997) Anesth Analg , vol.85 , pp. 1258-1267
    • Laupacis, A.1    Fergusson, D.2
  • 43
    • 0031437079 scopus 로고    scopus 로고
    • Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: A randomized, blinded clinical trial
    • Bennett-Guerrero E, Sorohan JG, Gurevich ML, et al. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial. Anesthesiology. 1997 ; 87: 1373-1380.
    • (1997) Anesthesiology , vol.87 , pp. 1373-1380
    • Bennett-Guerrero, E.1    Sorohan, J.G.2    Gurevich, M.L.3
  • 44
    • 10244240505 scopus 로고    scopus 로고
    • Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid
    • Vander Salm TJ, Kaur S, Lancey RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg. 1996 ; 112: 1098-1107.
    • (1996) J Thorac Cardiovasc Surg , vol.112 , pp. 1098-1107
    • Vander Salm, T.J.1    Kaur, S.2    Lancey, R.A.3
  • 45
    • 4444380033 scopus 로고    scopus 로고
    • Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
    • Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004 ; 128: 442-448.
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 442-448
    • Sedrakyan, A.1    Treasure, T.2    Elefteriades, J.A.3
  • 46
    • 0033862187 scopus 로고    scopus 로고
    • The antithrombotic effect of aprotinin: Actions mediated via the protease-activated receptor-1
    • Poullis M, Manning R, Laffan M, et al. The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor-1. J Thorac Cardiovasc Surg. 2000 ; 120: 370-378.
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 370-378
    • Poullis, M.1    Manning, R.2    Laffan, M.3
  • 47
    • 0035163406 scopus 로고    scopus 로고
    • Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
    • Despotis GJ, Avidan MS, Hogue Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg. 2001 ; 72: S1821 - S1831.
    • (2001) Ann Thorac Surg , vol.72
    • Despotis, G.J.1    Avidan, M.S.2    Hogue, Jr.3
  • 48
    • 0032178036 scopus 로고    scopus 로고
    • Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest
    • Eaton MP, Deeb GM. Aprotinin versus epsilon-aminocaproic acid for aortic surgery using deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 1998 ; 12: 548-552.
    • (1998) J Cardiothorac Vasc Anesth , vol.12 , pp. 548-552
    • Eaton, M.P.1    Deeb, G.M.2
  • 49
    • 24644517175 scopus 로고    scopus 로고
    • Pharmacologic cerebral capillary blood flow improvement after deep hypothermic circulatory arrest: An intravital fluorescence microscopy study in pigs
    • Ben Mime L, Arnhold S, Fischer JH, et al. Pharmacologic cerebral capillary blood flow improvement after deep hypothermic circulatory arrest: an intravital fluorescence microscopy study in pigs. J Thorac Cardiovasc Surg. 2005 ; 130: 670-676.
    • (2005) J Thorac Cardiovasc Surg , vol.130 , pp. 670-676
    • Ben Mime, L.1    Arnhold, S.2    Fischer, J.H.3
  • 50
    • 22144486965 scopus 로고    scopus 로고
    • Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest
    • Straub A, Azevedo R, Beierlein W, et al. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost. 2005 ; 94: 115-122.
    • (2005) Thromb Haemost , vol.94 , pp. 115-122
    • Straub, A.1    Azevedo, R.2    Beierlein, W.3
  • 51
    • 17444367990 scopus 로고    scopus 로고
    • Hypothermiainduced platelet aggregation: No effect of aprotinin (trasylol) but inhibition by eptifibatide (integrelin)
    • Straub A, Azevedo R, Beierlein W, et al. Hypothermiainduced platelet aggregation: no effect of aprotinin (trasylol) but inhibition by eptifibatide (integrelin). Thorac Cardiovasc Surg. 2005 ; 53: 80-84.
    • (2005) Thorac Cardiovasc Surg , vol.53 , pp. 80-84
    • Straub, A.1    Azevedo, R.2    Beierlein, W.3
  • 52
    • 0033932191 scopus 로고    scopus 로고
    • Use of recombinant-hirudin in pulmonary thromboendarterectomy
    • Rubens, FD, Sabloff M, Wells PS, et al. Use of recombinant-hirudin in pulmonary thromboendarterectomy. Ann Thorac Surg. 2000 ; 69: 1942-1943.
    • (2000) Ann Thorac Surg , vol.69 , pp. 1942-1943
    • Rubens, F.D.1    Sabloff, M.2    Wells, P.S.3
  • 53
    • 0036259197 scopus 로고    scopus 로고
    • Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: A pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia
    • Koster A, Sanger S, Knorig J, et al. Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J. 2002 ; 48: 106-109.
    • (2002) ASAIO J , vol.48 , pp. 106-109
    • Koster, A.1    Sanger, S.2    Knorig, J.3
  • 54
    • 0342953146 scopus 로고    scopus 로고
    • Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage
    • Mossinger H, Dietrich W. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg. 1998 ; 65 (6 suppl). S45 - S50.
    • (1998) Ann Thorac Surg , vol.65 , Issue.6 SUPPL.
    • Mossinger, H.1    Dietrich, W.2
  • 55
    • 0031057652 scopus 로고    scopus 로고
    • Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass
    • Chan AK, Leaker M, Burrows FA, et al. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost. 1997 ; 77: 270-277.
    • (1997) Thromb Haemost , vol.77 , pp. 270-277
    • Chan, A.K.1    Leaker, M.2    Burrows, F.A.3
  • 56
    • 0018655358 scopus 로고
    • Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children
    • Pang LM, Stalcup SA, Lipset JS, et al. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children. Circulation. 1979 ; 60: 1503-1507.
    • (1979) Circulation , vol.60 , pp. 1503-1507
    • Pang, L.M.1    Stalcup, S.A.2    Lipset, J.S.3
  • 57
    • 0032776365 scopus 로고    scopus 로고
    • Aprotinin in deep hypothermic circulatory arrest
    • Smith CR, Spanier TB. Aprotinin in deep hypothermic circulatory arrest. Ann Thorac Surg. 1999 ; 68: 278-286.
    • (1999) Ann Thorac Surg , vol.68 , pp. 278-286
    • Smith, C.R.1    Spanier, T.B.2
  • 58
    • 0012541372 scopus 로고
    • Transfusion medicine and coagulation disorders
    • Kaplan JA, ed. Philadelphia: WB Saunders;
    • Horrow J. Transfusion medicine and coagulation disorders. In: Kaplan JA, ed. Cardiac Anesthesia. Philadelphia: WB Saunders ; 1987: 111-1154.
    • (1987) Cardiac Anesthesia , pp. 111-1154
    • Horrow, J.1
  • 59
    • 0016590629 scopus 로고
    • Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery
    • Nagaoka H, Katori M. Inhibition of kinin formation by a kallikrein inhibitor during extracorporeal circulation in open-heart surgery. Circulation. 1975 ; 52: 325-332.
    • (1975) Circulation , vol.52 , pp. 325-332
    • Nagaoka, H.1    Katori, M.2
  • 60
    • 0025992843 scopus 로고
    • Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass
    • Blauhut B, Gross C, Necek S, et al. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991 ; 101: 958-967.
    • (1991) J Thorac Cardiovasc Surg , vol.101 , pp. 958-967
    • Blauhut, B.1    Gross, C.2    Necek, S.3
  • 61
    • 0028317074 scopus 로고
    • Aprotinin effect on platelet function and clotting during cardiopulmonary bypass
    • Tabuchi N, DeHann J, Boonstra PW, et al. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. Eur J Cardiothorac Surg. 1994 ; 8: 87-90, 1994
    • (1994) Eur J Cardiothorac Surg , vol.8 , pp. 87-90
    • Tabuchi, N.1    Dehann, J.2    Boonstra, P.W.3
  • 62
    • 0027216882 scopus 로고
    • Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery
    • Huang H, Ding W, Su Z, et al. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg. 1993 ; 106: 11-18.
    • (1993) J Thorac Cardiovasc Surg , vol.106 , pp. 11-18
    • Huang, H.1    Ding, W.2    Su, Z.3
  • 63
    • 0030791587 scopus 로고    scopus 로고
    • Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass
    • Shigeta O, Kojima H, Jikuya T, et al. Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass. Circulation. 1997 ; 96: 569-574.
    • (1997) Circulation , vol.96 , pp. 569-574
    • Shigeta, O.1    Kojima, H.2    Jikuya, T.3
  • 64
    • 0030060802 scopus 로고    scopus 로고
    • Reducing thrombin formation during cardiopulmonary bypass: Is there a benefit of the additional anticoagulant action of aprotinin?
    • Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin? J Cardiovasc Pharmacol. 1996 ; 27 (suppl 1). S50 - S57.
    • (1996) J Cardiovasc Pharmacol , vol.27 , Issue.SUPPL. 1
    • Dietrich, W.1
  • 65
    • 0027243485 scopus 로고
    • Reduction of heparin binding to and inhibition of platelets by aprotinin
    • John LC, Rees GM, Kovacs IB. Reduction of heparin binding to and inhibition of platelets by aprotinin. Ann Thorac Surg. 1993 ; 55: 1175-1179.
    • (1993) Ann Thorac Surg , vol.55 , pp. 1175-1179
    • John, L.C.1    Rees, G.M.2    Kovacs, I.B.3
  • 66
    • 0035656032 scopus 로고    scopus 로고
    • The antithrombotic and antiinflammatory mechanisms of action of aprotinin
    • Landis RC, Asimakopoulos G, Poullis M, et al. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg. 2001 ; 72: 2169-2175.
    • (2001) Ann Thorac Surg , vol.72 , pp. 2169-2175
    • Landis, R.C.1    Asimakopoulos, G.2    Poullis, M.3
  • 67
    • 0035171791 scopus 로고    scopus 로고
    • New antiinflammatory and platelet-preserving effects of aprotinin
    • Landis RC, Haskard DO, Taylor KM. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg. 2001 ; 72: S1808 - S1813.
    • (2001) Ann Thorac Surg , vol.72
    • Landis, R.C.1    Haskard, D.O.2    Taylor, K.M.3
  • 68
    • 0025142843 scopus 로고
    • Aprotinin in pediatric cardiac surgery
    • Elliott MJ, Allen A. Aprotinin in pediatric cardiac surgery. Perfusion. 1990 ; 5: 73-76.
    • (1990) Perfusion , vol.5 , pp. 73-76
    • Elliott, M.J.1    Allen, A.2
  • 69
    • 0007636102 scopus 로고
    • Studies on the cause of bleeding during and after surgery with heart-lung-machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment
    • McConn R, ed. New York: Raven;
    • Popov-Cenic S, Urban AE, Noe G. Studies on the cause of bleeding during and after surgery with heart-lung-machine in children with cyanotic and acyanotic congenital cardiac defects and their prophylactic treatment. In: McConn R, ed. Role of Chemical Mediators in the Pathophysiology of Acute Illness Injury. New York: Raven ; 1982: 229-242.
    • (1982) Role of Chemical Mediators in the Pathophysiology of Acute Illness Injury , pp. 229-242
    • Popov-Cenic, S.1    Urban, A.E.2    Noe, G.3
  • 70
    • 0029436203 scopus 로고
    • Aprotinin in children undergoing repair of congenital heart defects
    • Penkoske PA, Entwistle LM, Marchak BE, et al. Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac Surg. 1995 ; 60: S529 - S532.
    • (1995) Ann Thorac Surg , vol.60
    • Penkoske, P.A.1    Entwistle, L.M.2    Marchak, B.E.3
  • 71
    • 0035114126 scopus 로고    scopus 로고
    • Pro. Aprotinin should be used in patients undergoing hypothermic circulatory arrest
    • Royston D. Pro. Aprotinin should be used in patients undergoing hypothermic circulatory arrest. J Cardiothorac Vasc Anesth. 2001 ; 15: 121-125.
    • (2001) J Cardiothorac Vasc Anesth , vol.15 , pp. 121-125
    • Royston, D.1
  • 72
    • 0037314646 scopus 로고    scopus 로고
    • High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery
    • Mossinger H, Dietrich W, Braun SL, et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg. 2003 ; 75: 430-437.
    • (2003) Ann Thorac Surg , vol.75 , pp. 430-437
    • Mossinger, H.1    Dietrich, W.2    Braun, S.L.3
  • 73
    • 0027173089 scopus 로고
    • Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations
    • Dietrich W, Mossinger H, Spannagl M, et al. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg. 1993 ; 105: 712-720.
    • (1993) J Thorac Cardiovasc Surg , vol.105 , pp. 712-720
    • Dietrich, W.1    Mossinger, H.2    Spannagl, M.3
  • 74
    • 2642580925 scopus 로고    scopus 로고
    • Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery
    • Oliver WC, Fass DN, Nuttall GA, et al. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2004 ; 127: 1670-1677.
    • (2004) J Thorac Cardiovasc Surg , vol.127 , pp. 1670-1677
    • Oliver, W.C.1    Fass, D.N.2    Nuttall, G.A.3
  • 75
    • 6844234430 scopus 로고
    • Influence of aprotinin on coagulation patterns and blood loss in infants undergoing surgery for congenital heart defects [abstract]
    • Mossinger HD, Spannagel M. Influence of aprotinin on coagulation patterns and blood loss in infants undergoing surgery for congenital heart defects [abstract]. Anesthesiology. 1991 ; 75: A77 - A77.
    • (1991) Anesthesiology , vol.75
    • Mossinger, H.D.1    Spannagel, M.2
  • 76
    • 0037167689 scopus 로고    scopus 로고
    • Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: Lessons learned from 115 consecutive patients
    • Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002 ; 106 (12 suppl 1). I82 - I89.
    • (2002) Circulation , vol.106 , Issue.12 SUPPL. 1
    • Tweddell, J.S.1    Hoffman, G.M.2    Mussatto, K.A.3
  • 77
    • 0037385540 scopus 로고    scopus 로고
    • Aprotinin reduces operative closure time and blood product use after pediatric bypass
    • Costello JM, Backer CL, deHoyos A, et al. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg. 2003 ; 75: 1261-1266.
    • (2003) Ann Thorac Surg , vol.75 , pp. 1261-1266
    • Costello, J.M.1    Backer, C.L.2    Dehoyos, A.3
  • 78
    • 0029958434 scopus 로고    scopus 로고
    • The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery
    • D'Errico CC, Shayevitz JR, Martindale SJ, et al. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg. 1996 ; 83: 1193-1199.
    • (1996) Anesth Analg , vol.83 , pp. 1193-1199
    • D'Errico, C.C.1    Shayevitz, J.R.2    Martindale, S.J.3
  • 79
    • 0031802907 scopus 로고    scopus 로고
    • Pharmacoeconomics analysis in a pediatric population
    • D'Errico CC. Pharmacoeconomics analysis in a pediatric population. Ann Thorac Surg. 1998 ; 65 (6 suppl). S52 - S54.
    • (1998) Ann Thorac Surg , vol.65 , Issue.6 SUPPL.
    • D'Errico, C.C.1
  • 80
    • 0028093457 scopus 로고
    • Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest
    • Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994 ; 58: 146-153.
    • (1994) Ann Thorac Surg , vol.58 , pp. 146-153
    • Aoki, M.1    Jonas, R.A.2    Nomura, F.3
  • 81
    • 31344467254 scopus 로고    scopus 로고
    • The risk associated with aprotinin in cardiac surgery
    • Mangano DT, Tudor IC, Dietzel C, et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006 ; 354: 353-365.
    • (2006) N Engl J Med , vol.354 , pp. 353-365
    • Mangano, D.T.1    Tudor, I.C.2    Dietzel, C.3
  • 82
    • 0035908943 scopus 로고    scopus 로고
    • Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest
    • Mora Mangano CT, Neville MJ, Hsu PH, et al. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest. Circulation. 2001 ; 104 (12 suppl 1). I276 - I281.
    • (2001) Circulation , vol.104 , Issue.12 SUPPL. 1
    • Mora Mangano, C.T.1    Neville, M.J.2    Ph, H.3
  • 83
    • 4444380033 scopus 로고    scopus 로고
    • Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
    • Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004 ; 128: 442-448.
    • (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 442-448
    • Sedrakyan, A.1    Treasure, T.2    Elefteriades, J.A.3
  • 84
    • 0031802754 scopus 로고    scopus 로고
    • Review of efficacy parameters
    • Pouard P. Review of efficacy parameters. Ann Thorac Surg. 1998 ; 65 (suppl 6). S40 - S43.
    • (1998) Ann Thorac Surg , vol.65 , Issue.SUPPL. 6
    • Pouard, P.1
  • 85
    • 0031030981 scopus 로고    scopus 로고
    • Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations
    • Dietrich W, Spath P, Ebell A, et al. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg. 1997 ; 113: 194-201.
    • (1997) J Thorac Cardiovasc Surg , vol.113 , pp. 194-201
    • Dietrich, W.1    Spath, P.2    Ebell, A.3
  • 86
    • 0037167647 scopus 로고    scopus 로고
    • Safety of aprotinin use and re-use in pediatric cardiothoracic surgery
    • Jaquiss RD, Ghanayem NS, Zacharisen MC, et al. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation. 2002 ; 106 (12 suppl 1). I90 - I94.
    • (2002) Circulation , vol.106 , Issue.12 SUPPL. 1
    • Jaquiss, R.D.1    Ghanayem, N.S.2    Zacharisen, M.C.3
  • 87
    • 0032439432 scopus 로고    scopus 로고
    • Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass
    • Williams GD, Bratton SL, Nielsen NJ, et al. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1998 ; 12: 633-638.
    • (1998) J Cardiothorac Vasc Anesth , vol.12 , pp. 633-638
    • Williams, G.D.1    Bratton, S.L.2    Nielsen, N.J.3
  • 88
    • 0034668795 scopus 로고    scopus 로고
    • Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system
    • Ries M, Zenker M, Gaffney PJ. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. Thromb Res. 2000 ; 100: 341-351.
    • (2000) Thromb Res , vol.100 , pp. 341-351
    • Ries, M.1    Zenker, M.2    Gaffney, P.J.3
  • 89
    • 0033787561 scopus 로고    scopus 로고
    • Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease
    • Chauhan S, Kumar BA, Rao BH, et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg. 2000 ; 70: 1308-1312.
    • (2000) Ann Thorac Surg , vol.70 , pp. 1308-1312
    • Chauhan, S.1    Kumar, B.A.2    Rao, B.H.3
  • 90
    • 13244295652 scopus 로고    scopus 로고
    • Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination?
    • Bulutcu FS, Ozbek U, Polat B, et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth. 2005 ; 15: 41-46.
    • (2005) Paediatr Anaesth , vol.15 , pp. 41-46
    • Bulutcu, F.S.1    Ozbek, U.2    Polat, B.3
  • 91
    • 1942423177 scopus 로고    scopus 로고
    • Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery
    • Chauhan S, Das SN, Bisoi A, et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth. 2004 ; 18: 141-143.
    • (2004) J Cardiothorac Vasc Anesth , vol.18 , pp. 141-143
    • Chauhan, S.1    Das, S.N.2    Bisoi, A.3
  • 92
    • 0030950836 scopus 로고    scopus 로고
    • The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery
    • Reid RW, Zimmerman AA, Laussen PC, et al. The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg. 1997 ; 84: 990-996.
    • (1997) Anesth Analg , vol.84 , pp. 990-996
    • Reid, R.W.1    Zimmerman, A.A.2    Laussen, P.C.3
  • 93
    • 0034047255 scopus 로고    scopus 로고
    • Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure
    • Gruber EM, Shukla AC, Reid RW, et al. Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure. J Cardiothorac Vasc Anesth. 2000 ; 14: 257-259.
    • (2000) J Cardiothorac Vasc Anesth , vol.14 , pp. 257-259
    • Gruber, E.M.1    Shukla, A.C.2    Reid, R.W.3
  • 94
    • 0025269232 scopus 로고
    • Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation
    • Andersson TLG, Solem JO, Tengborn L, et al. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation. 1990 ; 81: 872-878.
    • (1990) Circulation , vol.81 , pp. 872-878
    • Tlg, A.1    Solem, J.O.2    Tengborn, L.3
  • 95
    • 0028885045 scopus 로고
    • The effect of desmopressin on reducing blood loss in cardiac surgery - A meta-analysis of double-blind, placebo-controlled trials
    • Cattaneo M, Harris AS, Stromberg U, et al. The effect of desmopressin on reducing blood loss in cardiac surgery - a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost. 1995 ; 74: 1064-1070.
    • (1995) Thromb Haemost , vol.74 , pp. 1064-1070
    • Cattaneo, M.1    Harris, A.S.2    Stromberg, U.3
  • 96
    • 0034528784 scopus 로고    scopus 로고
    • Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations
    • Oliver WC, Santrach PJ, Danielson GK, et al. Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Ann Thorac Surg. 2000 ; 70: 1923-1930.
    • (2000) Ann Thorac Surg , vol.70 , pp. 1923-1930
    • Oliver, W.C.1    Santrach, P.J.2    Danielson, G.K.3
  • 97
    • 14944387143 scopus 로고    scopus 로고
    • Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease
    • Razon Y, Erez E, Vidne B, et al. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth. 2005 ; 15: 235-240.
    • (2005) Paediatr Anaesth , vol.15 , pp. 235-240
    • Razon, Y.1    Erez, E.2    Vidne, B.3
  • 98
    • 16544374365 scopus 로고    scopus 로고
    • Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients
    • Tobias JD, Simsic JM, Weinstein S, et al. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med. 2004 ; 19: 270-273.
    • (2004) J Intensive Care Med , vol.19 , pp. 270-273
    • Tobias, J.D.1    Simsic, J.M.2    Weinstein, S.3
  • 99
    • 22144466560 scopus 로고    scopus 로고
    • Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery
    • Wittenstein B, Ng C, Ravn H, et al. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med. 2005 ; 6: 473-476.
    • (2005) Pediatr Crit Care Med , vol.6 , pp. 473-476
    • Wittenstein, B.1    Ng, C.2    Ravn, H.3
  • 100
    • 12544249629 scopus 로고    scopus 로고
    • Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis
    • Karkouti K, Beattie WS, Wijeysundera DN, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion. 2005 ; 45: 26-34.
    • (2005) Transfusion , vol.45 , pp. 26-34
    • Karkouti, K.1    Beattie, W.S.2    Wijeysundera, D.N.3
  • 101
    • 0036241743 scopus 로고    scopus 로고
    • Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
    • Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg. 2002 ; 94: 1369-1371.
    • (2002) Anesth Analg , vol.94 , pp. 1369-1371
    • Dietrich, W.1    Spannagl, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.